Inspire Medical Systems (INSP)

230.92 -1.72%
Dec 08 close; Powered by Koyfin
Pros
Revenue growth higher than the industry and sector averages
Company’s profitability is improving
Buy analyst rating
Average analyst stock price above current stock price
Cons
Stock price high relative to the 52-week range
Forward P/B ratio high relative to industry peers
Forward P/S ratio high relative to industry peers
High short share of float
High short interest

Pros

  1. INSP quarterly revenue growth was 72.60%, higher than the industry and sector average revenue growth (7.64% and 6.06%, respectively). See INSP revenue growth chart.
  2. INSP profitability is improving. The YoY profit margin change was 51.49 percentage points. See INSP profitability chart.
  3. INSP average analyst rating is Buy. See INSP analyst rating chart.
  4. INSP average analyst price target ($282.78) is above its current price ($239.49). See INSP price target chart.

Cons

  1. INSP stock price ($239.49) is close to the 52-week high ($241.57). Perhaps now is a good time to sell? See INSP price chart.
  2. INSP Price/Book ratio is 28.22, which is high compared to its industry peers’ P/B ratios. See INSP forward Price/Book ratio chart.
  3. INSP Price/Sales ratio is 21.78, which is high compared to its industry peers’ P/S ratios. See INSP forward Price/Sales ratio chart.
  4. INSP short share of float is 4.83%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See INSP short share of float chart.
  5. INSP short interest (days to cover the shorts) ratio is 4.67. The stock garners more short interest than the average industry, sector or S&P 500 stock. See INSP short interest ratio chart.